Report Detail
Global (United States, European Union and China) Drug-Eluting Stent Market Research Report 2019-2025
- RnM3579944 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body’s natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.
The growing prevalence of these diseases is due to factors such as smoking, obesity, alcohol consumption, and unhealthy lifestyle. Furthermore, the rapidly increasing older population is driving the market because aging increase the chances of developing cardiovascular diseases including atherosclerosis.
The global market for the drug-eluting stent is highly fragmented due to the presence of several well-established vendors. The competition is expected to intensify with an increase in product portfolio extensions with next-generation products, technological innovations, and mergers and acquisitions.
In 2019, the market size of Drug-Eluting Stent is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug-Eluting Stent.
This report studies the global market size of Drug-Eluting Stent, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug-Eluting Stent production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
Biosensors International Group
Boston Scientific
Medtronic
Terumo Corporation
Biotronik
Cook Medical
Envision Scientific
Lepu Medical
Meril Life Sciences
MicroPort Medical
Opto Circuits
Shandong JW Medical Systems
STENTYS
Market Segment by Product Type
ZES-BP
EES
ZES
SES
PES
Market Segment by Application
Cath labs
Hospitals
Ambulatory surgical centers (ASCs)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug-Eluting Stent status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug-Eluting Stent manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drug-Eluting Stent are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Drug-Eluting Stent Market Size Growth Rate by Type (2019-2025)
- 1.3.2 ZES-BP
- 1.3.3 EES
- 1.3.4 ZES
- 1.3.5 SES
- 1.3.6 PES
- 1.4 Market Segment by Application
- 1.4.1 Global Drug-Eluting Stent Market Share by Application (2019-2025)
- 1.4.2 Cath labs
- 1.4.3 Hospitals
- 1.4.4 Ambulatory surgical centers (ASCs)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Drug-Eluting Stent Production Value 2014-2025
- 2.1.2 Global Drug-Eluting Stent Production 2014-2025
- 2.1.3 Global Drug-Eluting Stent Capacity 2014-2025
- 2.1.4 Global Drug-Eluting Stent Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Drug-Eluting Stent Market Size CAGR of Key Regions
- 2.2.2 Global Drug-Eluting Stent Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Drug-Eluting Stent Capacity by Manufacturers
- 3.1.2 Global Drug-Eluting Stent Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Drug-Eluting Stent Revenue by Manufacturers (2014-2019)
- 3.2.2 Drug-Eluting Stent Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Drug-Eluting Stent Market Concentration Ratio (CR5 and HHI)
- 3.3 Drug-Eluting Stent Price by Manufacturers
- 3.4 Key Manufacturers Drug-Eluting Stent Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Drug-Eluting Stent Market
- 3.6 Key Manufacturers Drug-Eluting Stent Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 ZES-BP Production and Production Value (2014-2019)
- 4.1.2 EES Production and Production Value (2014-2019)
- 4.1.3 ZES Production and Production Value (2014-2019)
- 4.1.4 SES Production and Production Value (2014-2019)
- 4.1.5 PES Production and Production Value (2014-2019)
- 4.2 Global Drug-Eluting Stent Production Market Share by Type
- 4.3 Global Drug-Eluting Stent Production Value Market Share by Type
- 4.4 Drug-Eluting Stent Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Drug-Eluting Stent Consumption by Application
6 Production by Regions
- 6.1 Global Drug-Eluting Stent Production (History Data) by Regions 2014-2019
- 6.2 Global Drug-Eluting Stent Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Drug-Eluting Stent Production Growth Rate 2014-2019
- 6.3.2 United States Drug-Eluting Stent Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Drug-Eluting Stent Import & Export
- 6.4 European Union
- 6.4.1 European Union Drug-Eluting Stent Production Growth Rate 2014-2019
- 6.4.2 European Union Drug-Eluting Stent Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Drug-Eluting Stent Import & Export
- 6.5 China
- 6.5.1 China Drug-Eluting Stent Production Growth Rate 2014-2019
- 6.5.2 China Drug-Eluting Stent Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Drug-Eluting Stent Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Drug-Eluting Stent Consumption by Regions
- 7.1 Global Drug-Eluting Stent Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Drug-Eluting Stent Consumption by Type
- 7.2.2 United States Drug-Eluting Stent Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Drug-Eluting Stent Consumption by Type
- 7.3.2 European Union Drug-Eluting Stent Consumption by Application
- 7.4 China
- 7.4.1 China Drug-Eluting Stent Consumption by Type
- 7.4.2 China Drug-Eluting Stent Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Drug-Eluting Stent Consumption by Type
- 7.5.2 Rest of World Drug-Eluting Stent Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Drug-Eluting Stent
- 8.1.4 Drug-Eluting Stent Product Introduction
- 8.1.5 Abbott Laboratories Recent Development
- 8.2 Biosensors International Group
- 8.2.1 Biosensors International Group Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Drug-Eluting Stent
- 8.2.4 Drug-Eluting Stent Product Introduction
- 8.2.5 Biosensors International Group Recent Development
- 8.3 Boston Scientific
- 8.3.1 Boston Scientific Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Drug-Eluting Stent
- 8.3.4 Drug-Eluting Stent Product Introduction
- 8.3.5 Boston Scientific Recent Development
- 8.4 Medtronic
- 8.4.1 Medtronic Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Drug-Eluting Stent
- 8.4.4 Drug-Eluting Stent Product Introduction
- 8.4.5 Medtronic Recent Development
- 8.5 Terumo Corporation
- 8.5.1 Terumo Corporation Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Drug-Eluting Stent
- 8.5.4 Drug-Eluting Stent Product Introduction
- 8.5.5 Terumo Corporation Recent Development
- 8.6 Biotronik
- 8.6.1 Biotronik Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Drug-Eluting Stent
- 8.6.4 Drug-Eluting Stent Product Introduction
- 8.6.5 Biotronik Recent Development
- 8.7 Cook Medical
- 8.7.1 Cook Medical Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Drug-Eluting Stent
- 8.7.4 Drug-Eluting Stent Product Introduction
- 8.7.5 Cook Medical Recent Development
- 8.8 Envision Scientific
- 8.8.1 Envision Scientific Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Drug-Eluting Stent
- 8.8.4 Drug-Eluting Stent Product Introduction
- 8.8.5 Envision Scientific Recent Development
- 8.9 Lepu Medical
- 8.9.1 Lepu Medical Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Drug-Eluting Stent
- 8.9.4 Drug-Eluting Stent Product Introduction
- 8.9.5 Lepu Medical Recent Development
- 8.10 Meril Life Sciences
- 8.10.1 Meril Life Sciences Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Drug-Eluting Stent
- 8.10.4 Drug-Eluting Stent Product Introduction
- 8.10.5 Meril Life Sciences Recent Development
- 8.11 MicroPort Medical
- 8.12 Opto Circuits
- 8.13 Shandong JW Medical Systems
- 8.14 STENTYS
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Drug-Eluting Stent Capacity, Production Forecast 2019-2025
- 9.1.2 Global Drug-Eluting Stent Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Drug-Eluting Stent Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Drug-Eluting Stent Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Drug-Eluting Stent Production Forecast by Type
- 9.7.2 Global Drug-Eluting Stent Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Drug-Eluting Stent Sales Channels
- 10.2.2 Drug-Eluting Stent Distributors
- 10.3 Drug-Eluting Stent Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Drug-Eluting Stent. Industry analysis & Market Report on Drug-Eluting Stent is a syndicated market report, published as Global (United States, European Union and China) Drug-Eluting Stent Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Drug-Eluting Stent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
